Zydus Lifesciences has won final approval from the US Food and Drug Administration (FDA) for Tavaborole Topical Solution, 5%. The approved product is a generic version of Kerydin Topical Solution. According to Zydus Lifesciences, Tavaborole topical solution has FDA approval for the treatment of fungal toenail infections. The Indian pharma company will manufacture the drug […]
Indian pharma company Lupin Limited has launched Tavaborole Topical Solution, 5% following regulatory approval from the US Food and Drug Administration (FDA). Tavaborole Topical Solution, 5%, is a generic version of Kerydin Topical Solution, 5%, owned by Anacor Pharmaceuticals. It is an oxaborole antifungal, which has been approved by the FDA for the topical treatment […]
